Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CDKN1A interacting zinc finger protein 1 (CIZ1) is a nuclear protein that interacts with p21 (CIP1/CDKN1A) and cyclin E, playing a key regulatory role in coordinating DNA replication and cell cycle progression at the G1/S transition. CIZ1 is anchored to the nuclear matrix and forms assemblies in specific replication foci, ensuring proper initiation of DNA synthesis. It also is essential for maintenance phase of X chromosome inactivation, binding directly to Xist long noncoding RNA via intrinsically disordered domains and thereby supporting epigenetic silencing in female cells. CIZ1's function extends to chromatin organization, and its deregulation—via mutation, alternative splicing, or abnormal expression—is implicated in a variety of human diseases, particularly cancers (where alternative circulating forms serve as potential biomarkers), neurological disorders (including dystonia and cognitive decline), and lymphoproliferative disease. Its multifunctional nature and role in pathological states make it a candidate novel therapeutic target for future investigation.
Not directly targeted by clinical drugs yet; theorized mechanisms may include blockade of its interaction with cell cycle proteins (e.g., p21/CIP1 or cyclin E), modulation of its RNA-binding capacity, or inhibition of its assembly formation in chromatin regulation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CDKN1A interacting zinc finger protein 1 (CIZ1).